Cutting edge: Antigen presentation to CD8 T cells after influenza A virus infection

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 29-33

  Ingulli, Elizabeth ^a,c   Funatake, Castle ^b   Jacovetty, Erica L ^a   Zanetti, Maurizio ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; EPITOPE; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; OVA 8; OVA-8; OVALBUMIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA A VIRUS INFECTION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DENDRITIC CELL; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; INTRANASAL DRUG ADMINISTRATION; LUNG; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS, H3N2 SUBTYPE; LUNG; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS;

EID: 59849112649     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.29     Document Type: Article

References (22)

1. Fiore, A. E., D. K. Shay, P. Haber, J. K. Iskander, T. M. Uyeki, G. Mootrey, J. S. Bresee, and N. J. Cox. 2007. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007.MMWR Recomm. Rep. 56: 1-54.
2. Salk, J., and D. Salk. 1977. Control of influenza and poliomyelitis with killed virus vaccines. Science 195: 834-847.
3. + T cells. J. Immunol. 144: 3980-3986.
4. + T cells. Immunol. Rev. 186: 221-233.
5. Castiglioni, P., D. S. Hall, E. L. Jacovetty, E. Ingulli, and M. Zanetti. 2008. Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells. J. Immunol. 180: 4956-4964.
6. Hamilton-Easton, A., and M. Eichelberger. 1995. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69: 6359-6366.
7. Eichelberger, M. C., M. L. Wang, W. Allan, R. G. Webster, and P. C. Doherty. 1991. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 72: 1695-1698.
8. + T cells in the draining lymph nodes in response to pulmonary virus infection. J. Immunol. 179: 391-399.
9. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
10. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
11. Filatenkov, A. A., E. L. Jacovetty, U. B. Fischer, J. M. Curtsinger, M. F. Mescher, and E. Ingulli. 2005. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. J. Immunol. 174: 6909-6917.
12. + T cell immunodominance hierarchies when antigen is limiting. J. Immunol. 177: 2917-2925.
13. + T cells during pulmonary influenza virus infection. J. Immunol. 173: 1209-1218.
14. Legge, K. L., and T. J. Braciale. 2003. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18: 265-277.
15. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172: 1996-2000.
16. + T cell responses in pathogen infections through antigen presentation. Adv. Exp. Med. Biol. 590: 31-42.
17. Junt, T., E. A. Moseman, M. Iannacone, S. Massberg, P. A. Lang, M. Boes, K. Fink, S. E. Henrickson, D. M. Shayakhmetov, N. C. Di Paolo, et al. 2007. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450: 110-114.
18. + T cells. J. Exp. Med. 185: 2133-2141.
19. Itano, A. A., S. J. McSorley, R. L. Reinhardt, B. D. Ehst, E. Ingulli, A. Y. Rudensky, and M. K. Jenkins. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47-57.
20. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
21. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170: 4437-4440.
22. - dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. Eur. J. Immunol. 38: 370-380.